Page 127 - 18F-FDG PET as biomarker in aggressive lymphoma; technical and clinical validation
P. 127
CHAPTER 6a
18F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-cell Lymphoma: The HOVON-84 Study
Coreline N. Burggraaff Pieternella J. Lugtenburg Anne I.J. Arens Martijn W. Heymans Sanne E. Wiegers Ronald Boellaard Josée M. Zijlstra
Jakoba J. Eertink Otto S. Hoekstra Bart de Keizer Bronno van der Holt Simone Pieplenbosch Henrica C.W. de Vet
On behalf of the HOVON Imaging Working Group and HOVON Lymphoma Working Group
Journal of Nuclear Medicine 2022; 63: 1001-1007.
